-
Mashup Score: 278
As I announced earlier this week, today is my last day as NIH Director. It has truly been my honor to lead this agency and to see firsthand the tremendous work that is being done here. Last month o…
Source: directorsblog.nih.govCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 162Statement on the departure of National Cancer Institute Director Dr. - 6 month(s) ago
Dr. Rathmell served as the 17th Director of NCI.
Source: www.nih.govCategories: General Medicine News, General HCPsTweet-
It’s been an extraordinary privilege to work alongside Dr. W. Kimryn Rathmell who today announced her departure as @NCIDirector. Her contributions to @theNCI & broader field of cancer research will continue to inspire progress in the fight against cancer. https://t.co/lrDbZKov4V
-
-
Mashup Score: 53
The ability to engineer complex biological tissues—such as the tiny air sacs inside our lungs or complex, branching blood vessels throughout our bodies—has vast potential to unlock fundamental biol…
Source: directorsblog.nih.govCategories: General Medicine News, General HCPsTweet-
In a process similar to traditional metal-casting, researchers have found a way to use the silvery metal gallium to produce accurate constructions of living tissues, a process that could lead to new biological insights. https://t.co/xHT5PjX0Tr #NIH @BUtweets @wyssinstitute
-
-
Mashup Score: 80Could Engineered Immune Cells Be Used to Treat People with Autoimmune Diseases and Organ Transplants while Reducing Infection Risks? - 6 month(s) ago
Millions of people in the U.S. have an autoimmune disease, from type 1 diabetes to inflammatory bowel disease, in which the immune system attacks the body’s own organs, tissues, or cells to cause d…
Source: directorsblog.nih.govCategories: General Medicine News, General HCPsTweet-
This week on my blog: a promising #NIH-funded study at @UCSF shows engineered immune cells can be used to treat autoimmune diseases like type 1 diabetes by targeting the immune system in specific areas only. https://t.co/LSibWaJRiB https://t.co/Y2EN1DIKPm
-
-
Mashup Score: 276What is metformin’s secret sauce? - 6 month(s) ago
The diabetes drug can target cells contributing to disease progression without harming normal, healthy cells, according to research
Source: news.northwestern.eduCategories: General Medicine News, General HCPsTweet-
Metformin is a diabetes med that reduces inflammation and has shown potential for slowing cancer growth and more. A new study in mice is helping scientists understand how the drug works by interfering with cell mitochondria. @NorthwesternU https://t.co/JILtSzaOzP
-
-
Mashup Score: 45
Background The prevalence of eczema has increased with industrialization. Industrial practices generate ambient air pollution, including fine particulate matter of diameter ≤ 2.5μm (PM2.5). Studies investigating the relationship between PM2.5 and eczema in the US are scarce. The objective of this study was to determine the risk of eczema with PM2.5 exposure in a diverse national cohort of American adults. Methods In this cross-sectional study, eczema cases in the All of Us Research Program were linked via three-digit zip code to average annual PM2.5 concentrations from the Center for Air, Climate, and Energy Solutions. Eczema cases and controls were compared using Pearson’s χ2 test for categorical variables and one-way analysis of variance for continuous variables. The relationship between PM2.5 and eczema was assessed via logistic regression adjusting for demographic factors, smoking, and atopic comorbidities. Results Individuals with eczema (n = 12,695) lived in areas with significan
Source: journals.plos.orgCategories: General Medicine News, General HCPsTweet-
A large study based on data from #NIH’s @AllofUsResearch program found that people with #eczema are more likely to live in zip codes with a high level of air pollution, suggesting an association between the two. https://t.co/sYXMKBOTYf
-
-
Mashup Score: 322024 Science Highlights from the NIH Director’s Blog - 6 month(s) ago
This year on the NIH Director’s Blog, we covered a wide range of NIH-supported research from across our institutes and centers. We explored exciting new findings that came from clinical trials and …
Source: directorsblog.nih.govCategories: General Medicine News, General HCPsTweet-
This year on my blog, we covered a wide range of #NIH-supported research. Highlights included learning more about the human brain, use of AI technology in health, clues about chronic autoimmune conditions, mental health & Long COVID. Read more: https://t.co/NSBfO2wkWQ
-
-
Mashup Score: 32
A complete blood count (CBC) screening is a routine exam requested by most physicians for healthy adults.Currently, the results of CBC tests are analyzed using a one-size-fits-all reference interval, but a new study led by researchers from Mass General Brigham suggests that this approach can lead to overlooked deviations in health. In a retrospective analysis, researchers show that these reference intervals, or setpoints, are unique to each patient. The study revealed that one healthy patient’s CBC setpoints can be distinguishable from 98 percent of other healthy adults.
Source: www.eurekalert.orgCategories: General Medicine News, General HCPsTweet-
New research from @MassGenBrigham finds that a one-size-fits-all approach to standard blood count tests may miss key health variations. Since everyone has unique set points, a personalized approach could improve diagnosis of certain diseases & conditions. https://t.co/Vef6tRguPD
-
-
Mashup Score: 63ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials - 7 month(s) ago
Clinical trials are essential for advancing new treatments that improve patient care and lives. But far too many clinical trials face challenges in identifying and enrolling eligible trial particip…
Source: directorsblog.nih.govCategories: General Medicine News, General HCPsTweet-
A new #AI tool developed by #NIH researchers could help clinicians quickly match their patients to clinical trials, a promising development that can help with study enrollment. More on my blog: https://t.co/IvUPkyrhCo
-
-
Mashup Score: 326NIH issues new policy to speed access to agency-funded research - 7 month(s) ago
The 12-month embargo period before manuscripts resulting from NIH funding must be made publicly available is removed.
Source: www.nih.govCategories: General Medicine News, General HCPsTweet-
In support of NIH’s commitment to accelerating access to #NIH-funded research results, we’ve released a new public access policy which requires posting of NIH-funded research results at the time of publication. Read more in my statement: https://t.co/HDhD4tB9a6 @WHOSTP
-
Sharing some final thoughts on the important role #NIH plays in science & in the lives of Americans. I wish the next NIH Director the greatest success in leading this great agency that has a long history of turning research discoveries into better health. https://t.co/9ZdmiMBeoJ